Inhibrx Biosciences (INBX) Shares Outstanding (Diluted Average) (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Shares Outstanding (Diluted Average) data on file, last reported at $15.5 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $15.5 million, up 3.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.5 million (up 3.36% YoY), and the FY2025 annual result was $15.5 million, up 3.36% from the prior year.
• Shares Outstanding (Diluted Average) held at $15.5 million in Q4 2025 per INBX's latest filing, from $15.5 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $15.5 million in Q4 2025 and troughed at $10.9 million in Q2 2023.
• A 3-year average of $14.0 million and a median of $14.8 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) soared 32.96% in 2024, then gained 3.36% in 2025.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $11.8 million in 2023, then grew by 27.17% to $15.0 million in 2024, then grew by 3.36% to $15.5 million in 2025.
• Business Quant data shows INBX's Shares Outstanding (Diluted Average) at $15.5 million in Q4 2025, $15.5 million in Q3 2025, and $15.5 million in Q2 2025.